SCHEMBL4375722

SCHEMBL4375722

C=CCC1(CC=C)OCC(C(O)C(F)(F)C(=O)O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2321974 0.88
SCHEMBL4795425 0.85
SCHEMBL7519620 0.82 MMP9 (0.35)
SCHEMBL13697137 0.74 HCRTR1 (0.32)
SCHEMBL4087184 0.74 HCRTR1 (0.32)
SCHEMBL14449048 0.74 HCRTR1 (0.32)
SCHEMBL756177 0.74 HCRTR1 (0.32)
SCHEMBL4795429 0.68
SCHEMBL7756780 0.68 MMP9 (0.35)
SCHEMBL4665617 0.68 MMP9 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281301-A1 Manufacturing Process of 2' ,2' - Difluoronucleoside and Intermediate DONG-A-PHARM.CO LTD (KR) 2009-11-12 US claimed
EP-1960378-A1 A MANUFACTURING PROCESS OF 2',2'-DIFLUORONUCLEOSIDE AND INTERMEDIATE Dong-A Pharmaceutical Co., Ltd. (KR) 2008-08-27 EP claimed
WO-2007069838-A1 A MANUFACTURING PROCESS OF 2',2'-DIFLUORONUCLEOSIDE AND INTERMEDIATE DONG-A PHARM.CO., LTD. (KR) 2007-06-21 WO claimed
EP-0306190-B1 Process for preparing intermediates useful in the preparation of 2',2'-difluoronucleosides LILLY CO ELI (US) 1998-04-08 EP claimed
US-20090281301-A1 Manufacturing Process of 2' ,2' - Difluoronucleoside and Intermediate DONG-A-PHARM.CO LTD (KR) 2009-11-12 US disclosed
EP-1960378-A1 A MANUFACTURING PROCESS OF 2',2'-DIFLUORONUCLEOSIDE AND INTERMEDIATE Dong-A Pharmaceutical Co., Ltd. (KR) 2008-08-27 EP disclosed
WO-2007069838-A1 A MANUFACTURING PROCESS OF 2',2'-DIFLUORONUCLEOSIDE AND INTERMEDIATE DONG-A PHARM.CO., LTD. (KR) 2007-06-21 WO disclosed